Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growth

Canadian Journal of Physiology and Pharmacology

Volumn 86, Issue 7, 2008, Pages 438-448

  Pons, Jennifer ^a   Kitlinska, Joanna ^a   Jacques, Danielle ^b   Perreault, Claudine ^b   Nader, Moni ^b   Everhart, Lindsay ^a   Zhang, Ying ^c   Zukowska, Zofia ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SHERBROOKE   (Canada)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Neuropeptide Y; Signaling; Vascular smooth muscle

Indexed keywords

1 NAPHTHALENESULFONIC ACID [4 [(4 AMINO 2 QUINAZOLINYLAMINO)METHYL]CYCLOHEXYLMETHYL]AMIDE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADENYLATE CYCLASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CELL GROWTH; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOTTING, WESTERN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL PROLIFERATION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT DYES; FORSKOLIN; FURA-2; MICROSCOPY, CONFOCAL; MITOSIS; MYOCYTES, SMOOTH MUSCLE; NEUROPEPTIDE Y; PROTEIN KINASE C; RATS; RECEPTORS, NEUROPEPTIDE Y; SIGNAL TRANSDUCTION;

EID: 46749111813     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y08-054     Document Type: Article

References (55)

1. AbdAlla, S., Lother, H., el Massiery, A., and Quitterer, U. 2001. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat. Med. 7: 1003-1009. doi:10.1038/nm0901-1003. PMID:11533702.
2. Balasubramaniam, A. 2002. Clinical potentials of neuropeptide Y family of hormones. Am. J. Surg. 183: 430-434. doi:10.1016/S0002-9610(02)00803-6. PMID:11975932.
3. Berglund, M.M., Hipskind, P.A., and Gehlert, D.R. 2003. Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp. Biol. Med. (Maywood), 228: 217-244. PMID:12626767.
4. Bischoff, A., Puttmann, K., Kotting, A., Moser, C., Buschauer, A., and Michel, M.C. 2001. Limited signal transduction repertoire of human Y(5) neuropeptide Y receptors expressed in HEC-1B cells. Peptides, 22: 387-394. doi:10.1016/S0196-9781(01)00346-1. PMID:11287093.
5. Bkaily, G., Pothier, P., D'Orléans-Juste, P., Simaan, M., Jacques, D., Jaalouk, D., et al. 1997. The use of confocal microscopy in the investigation of cell structure and function in the heart, vascular endothelium and smooth muscle cells. Mol. Cell. Biochem. 172: 171-194. doi:10.1023/A:1006840228104. PMID:9278244.
6. 2+ channel in aortic smooth muscle cells via a pertussis toxin and cholera toxin sensitive G-protein. Mol. Cell. Biochem. 183: 39-47. doi:10.1023/A:1006887714302. PMID:9655176.
7. Bkaily, G., Jacques, D., and Pothier, P. 1999. Use of confocal microscopy to investigate cell structure and function. Methods Enzymol. 307: 119-135. PMID:10506971.
8. Bkaily, G., Choufani, S., Hassan, G., El-Bizri, N., Jacques, D., and D'Orléans-Juste, P. 2000. Presence of functional endothelin-1 receptors in nuclear membranes of human aortic vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 36(Suppl 1):S414-S417. PMID:11078437.
9. Bkaily, G., Nader, M., Avedanian, L., Choufani, S., Jacques, D., D'Orléans-Juste, P., et al. 2006. G-protein-coupled receptors, channels, and Na+-H+ exchanger in nuclear membranes of heart, hepatic, vascular endothelial, and smooth muscle cells. Can. J. Physiol. Pharmacol. 84: 431-441. doi:10.1139/Y06-002. PMID:16902588.
10. Bornfeldt, K.E., and Krebs, E.G. 1999. Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle. Cell. Signal. 11: 465-477. doi:10.1016/S0898-6568(99)00020-0. PMID:10405757.
11. Cabrele, C., Langer, M., Bader, R., Wieland, H.A., Doods, H.N., Zerbe, O., et al. 2000. The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats. J. Biol. Chem. 275: 36043-36048. doi:10.1074/jbc.M000626200. PMID:10944518.
12. Claing, A., Shbaklo, H., Plante, M., Bkaily, G., and D'Orléans- Juste, P. 2002. Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein. Br. J. Pharmacol. 135: 433-443. doi:10.1038/sj.bjp.0704441. PMID:11815379.
13. Dumont, Y., and Quirion, R. 2006. An overview of neuropeptide Y: pharmacology to molecular biology and receptor localization. In NPY family of peptides in neurobiology, cardiovascular and metabolic disorders: from genes to therapeutics. Edited by Z. Zukowska and G. Feuerstein. Bikrhauser Verlag, Basel, Switzerland. pp. 7-33.
14. Ekstrand, A.J., Cao, R., Bjorndahl, M., Nystrom, S., Jonsson-Rylander, A.C., Hassani, H., et al. 2003. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc. Natl. Acad. Sci. U.S.A. 100: 6033-6038. doi:10.1073/pnas. 1135965100. PMID:12730369.
15. Gardoni, F., Bellone, C., Cattabeni, F., and Di Luca, M. 2001. Protein kinase C activation modulates alpha-calmodulin kinase II binding to NR2A subunit of N-methyl-D-aspartate receptor complex. J. Biol. Chem. 276: 7609-7613. doi:10.1074/jbc.M009922200. PMID:11104776.
16. Gehlert, D.R., Schober, D.A., Morin, M., and Berglund, M.M. 2007. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties. Biochem Pharmacol. 74: 1652-1664. doi:10.1016/j.bcp.2007.08.017. PMID:17897631.
17. Ginnan, R., Pfleiderer, P.J., Pumiglia, K., and Singer, H.A. 2004. PKC-delta and CaMKII-delta 2 mediate ATP-dependent activation of ERK1/2 in vascular smooth muscle. Am. J. Physiol. Cell Physiol. 286: C1281-C1289. doi:10.1152/ajpcell.00202.2003. PMID:14749212.
18. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260: 3440-3450. PMID:3838314.
19. Hafner, S., Adler, H.S., Mischak, H., Janosch, P., Heidecker, G., Wolfman, A., et al. 1994. Mechanism of inhibition of Raf-1 by protein kinase A. Mol. Cell. Biol. 14: 6696-6703. PMID:7935389.
20. Hansel, D.E., Eipper, B.A., and Ronnett, G.V. 2001. Neuropeptide Y functions as a neuroproliferative factor. Nature, 410: 940-944. doi:10.1038/35073601. PMID:11309620.
21. Illario, M., Cavallo, A.L., Bayer, K.U., Di Matola, T., Fenzi, G., Rossi, G., et al. 2003. Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ERK activation. J. Biol. Chem. 278: 45101-45108. doi:10.1074/jbc.M305355200. PMID:12954639.
22. Illario, M., Cavallo, A.L., Monaco, S., Di Vito, E., Mueller, F., Marzano, L.A., et al. 2005. Fibronectin-induced proliferation in thyroid cells is mediated by alphavbeta3 integrin through Ras/Raf-1/MEK/ERK and calcium/CaMKII signals. J. Clin. Endocrinol. Metab. 90: 2865-2873. doi:10.1210/jc.2004- 1520. PMID:15687337.
23. 2+ in heart and vascular smooth muscle cells. Can. J. Physiol. Pharmacol. 78: 162-172. doi:10.1139/cjpp-78-2-162. PMID:10737679.
24. Jacques, D., Sader, S., Perreault, C., Fournier, A., Pelletier, G., Beck-Sickinger, A.G., et al. 2003. Presence of neuropeptide Y and the Y1 receptor in the plasma membrane and nuclear envelope of human endocardial endothelial cells: modulation of intracellular calcium. Can. J. Physiol. Pharmacol. 81: 288-300. doi:10.1139/y02-165. PMID:12733827.
25. Kitlinska, J., Lee, E.W., Movafagh, S., Pons, J., and Zukowska, Z. 2002. Neuropeptide Y-induced angiogenesis in aging. Peptides, 23: 71-77. doi:10.1016/S0196-9781(01)00581-2. PMID:11814620.
26. Kitlinska, J., Abe, K., Kuo, L., Pons, J., Yu, M., Li, L., et al. 2005. Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors. Cancer Res. 65: 1719-1728. doi:10.1158/0008-5472.CAN-04-2192. PMID:15753367.
27. Koulu, M., Movafagh, S., Tuohimaa, J., Jaakkola, U., Kallio, J., Pesonen, U., et al. 2004. Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization. Ann. Med. 36: 232-240. doi:10.1080/07853890410031236. PMID:15181979.
28. Kuo, L.E., Kitlinska, J.B., Tilan, J.U., Li, L., Baker, S.B., Johnson, M.D., et al. 2007. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat. Med. 13: 803-811. doi:10.1038/nm1611. PMID:17603492.
29. Lee, E.W., Michalkiewicz, M., Kitlinska, J., Kalezic, I., Switalska, H., Yoo, P., et al. 2003. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J. Clin. Invest. 111: 1853-1862. PMID:12813021.
30. Li, L., Lee, E.W., Ji, H., and Zukowska, Z. 2003. Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery. Arterioscler. Thromb. Vasc. Biol. 23: 1204-1210. doi:10.1161/01.ATV.0000071349.30914. 25. PMID:12689918.
31. Li, L., Jonsson-Rylander, A.C., Abe, K., and Zukowska, Z. 2005. Chronic stress induces rapid occlusion of angioplasty-injured rat carotid artery by activating neuropeptide Y and its Y1 receptors. Arterioscler. Thromb. Vasc. Biol. 25: 2075-2080. doi:10.1161/01.ATV.0000179601.19888.19. PMID:16051880.
32. Liebmann, C. 2001. Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity. Cell. Signal. 13: 777-785. doi:10.1016/S0898-6568(01)00192-9. PMID:11583913.
33. Malmstrom, R.E. 2000. Neuropeptide Y Y1 receptor mediated mesenteric vasoconstriction in the pig in vivo. Regul. Pept. 95: 59-63. doi:10.1016/S0167-0115(00)00128-2. PMID:11062333.
34. Michel, M.C., Beck-Sickinger, A., Cox, H., Doods, H.N., Herzog, H., Larhammar, D., et al. 1998. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 50: 143-150. PMID:9549761.
35. Movafagh, S., Hobson, J.P., Spiegel, S., Kleinman, H.K., and Zukowska, Z. 2006. Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors. FASEB J. 20: 1924-1926. doi:10.1096/fj.05-4770fje. PMID:16891622.
36. 2+/calmodulin-dependent protein kinase II and cytosolic phospholipase A2 contribute to mitogenic signaling in myeloblastic leukemia U-937 cells. J. Pharmacol. Exp. Ther. 298: 272-278. PMID:11408552.
37. Nilsson, T., and Edvinsson, L. 2000. Neuropeptide Y stimulates DNA synthesis in human vascular smooth muscle cells through neuropeptide Y Y1 receptors. Can. J. Physiol. Pharmacol. 78: 256-259. doi:10.1139/cjpp-78- 3-256. PMID:10721818.
38. Noda, M., Higashida, H., Aoki, S., and Wada, K. 2004. Multiple signal transduction pathways mediated by 5-HT receptors. Mol. Neurobiol. 29: 31-39. doi:10.1385/MN:29:1:31. PMID:15034221.
39. Pellieux, C., Sauthier, T., Domenighetti, A., Marsh, D.J., Palmiter, R.D., Brunner, H.R., et al. 2000. Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors. Proc. Natl. Acad. Sci. U.S.A. 97: 1595-1600. doi:10.1073/pnas.030533197. PMID:10660688.
40. i in single cells. Prog. Clin. Biol. Res. 210: 53-56. PMID:3754335.
41. Pons, J., Kitlinska, J., Ji, H., Lee, E.W., and Zukowska, Z. 2003. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system. Can. J. Physiol. Pharmacol. 81: 177-185. doi:10.1139/y02-166. PMID:12710532.
42. Putney, J.W. 2002. PLC-gamma: an old player has a new role. Nat. Cell Biol. 4: E280-E281. doi:10.1038/ncb1202-e280. PMID:12461531.
43. Schieffer, B., Drexler, H., Ling, B.N., and Marrero, M.B. 1997. G protein-coupled receptors control vascular smooth muscle cell proliferation via pp60c-src and p21ras. Am. J. Physiol. 272: C2019-C2030. PMID:9227431.
44. Shigeri, Y., and Fujimoto, M. 1993. Neuropeptide Y stimulates DNA synthesis in vascular smooth muscle cells. Neurosci. Lett. 149: 19-22. doi:10.1016/0304-3940(93)90337-K. PMID:8469373.
45. 2+ concentration via phospholipase C-dependent pathway in porcine aortic smooth muscle cells. J. Biochem. 118: 515-520. PMID:8690710.
46. Tsuda, Y., Okazaki, M., Uezono, Y., Osajima, A., Kato, H., Okuda, H., et al. 2002. Activation of extracellular signal-regulated kinases is essential for pressure-induced proliferation of vascular smooth muscle cells. Eur. J. Pharmacol. 446: 15-24. doi:10.1016/S0014-2999(02)01811-3. PMID:12098581.
47. Wahlestedt, C., Hakanson, R., Vaz, C.A., and Zukowska-Grojec, Z. 1990. Norepinephrine and neuropeptide Y: vasoconstrictor cooperation in vivo and in vitro. Am. J. Physiol. 258: R736-R742. PMID:1969241.
48. 2+/CaM induces synaptic potentiation requiring CaMKII and PKC activity. Neuron, 15: 443-452. doi:10.1016/0896-6273(95)90048-9. PMID:7646896.
49. Wheway, J., Herzog, H., and Mackay, F. 2007. The Y1 receptor for NPY: a key modulator of the adaptive immune system. Peptides, 28: 453-458. doi:10.1016/j.peptides.2006.09.030. PMID:17240480.
50. Wong, S.T., Baker, L.P., Trinh, K., Hetman, M., Suzuki, L.A., Storm, D.R., et al. 2001. Adenylyl cyclase 3 mediates prostaglandin E(2)-induced growth inhibition in arterial smooth muscle cells. J. Biol. Chem. 276: 34206-34212. doi:10.1074/jbc.M103923200. PMID:11432866.
51. 2+/calmodulin- dependent protein kinase II inhibition by heparin in mesangial cells. Am. J. Physiol. Renal Physiol. 288: F142-F149. doi:10.1152/ajprenal.00145.2004. PMID:15383398.
52. Zukowska, Z., Pons, J., Lee, E.W., and Li, L. 2003. Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system? Can. J. Physiol. Pharmacol. 81: 89-94. doi:10.1139/y03-006. PMID:12710520.
53. Zukowska-Grojec, Z., Pruszczyk, P., Colton, C., Yao, J., Shen, G.H., Myers, A.K., et al. 1993. Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides, 14: 263-268. doi:10.1016/0196-9781(93) 90040-N. PMID:8483806.
54. Zukowska-Grojec, Z., Karwatowska-Prokopczuk, E., Fisher, T.A., and Ji, H. 1998a. Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors. Regul. Pept. 75-76: 231-238. doi:10.1016/S0167-0115(98)00073-1. PMID:9802414.
55. Zukowska-Grojec, Z., Karwatowska-Prokopczuk, E., Rose, W., Rone, J., Movafagh, S., Ji, H., et al. 1998b. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ. Res. 83: 187-195. PMID:9686758.